Antia Laboratories Inc.

New products

No new product at this time


CAS: 275371-94-3

Mol.Formula: C152H232N40O45

Mol.Weight: 3339.75

Purity: 95% (HPLC)

Sequence: H2N-His-2-methyl-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-2-methyl-Ala-Arg-CONH2


For treatment of type 2 diabetes being co-developed by Ipsen and Roche.


1."Taspoglutide, a novel human once-weekly analogue of glucagon-like peptide-1, improves glucose homeostasis and body weight in the Zucker diabetic fatty rat."
E. Sebokova et al: Diabetes, Obesity and Metabolism 12: 674-682 (2010) Full text

2."Safety and tolerability of high doses of taspoglutide, a once-weekly human GLP-1 analogue, in diabetic patients treated with metformin: a randomized double-blind placebo-controlled study."
R. Ratner et al.: Diabet. Med. 27, 556–562 (2010) Full text

3."Determination of Taspoglutide in Human and Animal Plasma Using Liquid Chromatography-Tandem Mass Spectrometry with Orthogonal Column-Switching."
Katja Heinig et al.: Anal. Chem. 81: 3705-3713 (2009) Full text


This product is custom synthesis, and delivery time is about 4 weeks.

The product is only for R&D purpose,not for human use.We will not take any responsibility for illegal use.